Their conversation centered around the evolving HER2-positive breast cancer treatment paradigm. The experts highlighted that although this disease was once associated with a poor prognosis, targeted ...

This is driven by low screening rates that lead to late-stage diagnoses. The report projects over 46,000 new adult cases this ...

The 2026 PSMA & Beyond conference featured a targeting the cell surface session and presentation by Dr. Rahul Aggarwal discussing DLL3 and whether target expression determines the method of targeting.

Bicycle Therapeutics is to cut its workforce by about 30 per cent and halve its operating costs as it switches focus on its pipeline. The Granta Park-based pharma company will reduce its headcount to ...

US FDA approves Agilent’s PD-L1 IHC 22C3 pharmDx, as companion diagnostic to aid in identifying patients with esophageal or GEJ carcinoma: Santa Clara, California Saturday, Marc ...

The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Dr. Jeremie Calais discussing a review of phase 1/2 compounds recently published. Without question, there ...

David Lyon is one of the rising number of young adults to be diagnosed with colorectal cancer.

Tumors contain many different types of cells organized in complex spatial patterns that can influence how the disease progresses. Because of this, it is hard to predict how a tumor will develop and ...

For oncology nurses caring for patients with KRAS G12C-mutant metastatic non–small cell lung cancer (NSCLC), new data from the phase 1 KANDLELIT-001 trial (NCT05067283) suggest ...